Food Safety Testing Device
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Drugs 1.2.3 Medical Devices 1.3 Market by Sale Channel 1.3.1 Global Prostate Cancer Therapeutics Market Share by Sale Channel: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Therapeutics Market Perspective (2017-2028) 2.2 Prostate Cancer Therapeutics Growth Trends by Region 2.2.1 Prostate Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Prostate Cancer Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Prostate Cancer Therapeutics Market Dynamics 2.3.1 Prostate Cancer Therapeutics Industry Trends 2.3.2 Prostate Cancer Therapeutics Market Drivers 2.3.3 Prostate Cancer Therapeutics Market Challenges 2.3.4 Prostate Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Therapeutics Players by Revenue 3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Therapeutics Revenue 3.4 Global Prostate Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2021 3.5 Prostate Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Prostate Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Therapeutics Breakdown Data by Type 4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2023-2028) 5 Prostate Cancer Therapeutics Breakdown Data by Sale Channel 5.1 Global Prostate Cancer Therapeutics Historic Market Size by Sale Channel (2017-2022) 5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2023-2028) 6 North America 6.1 North America Prostate Cancer Therapeutics Market Size (2017-2028) 6.2 North America Prostate Cancer Therapeutics Market Size by Country (2017-2022) 6.3 North America Prostate Cancer Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Prostate Cancer Therapeutics Market Size (2017-2028) 7.2 Europe Prostate Cancer Therapeutics Market Size by Country (2017-2022) 7.3 Europe Prostate Cancer Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Prostate Cancer Therapeutics Market Size (2017-2028) 9.2 Latin America Prostate Cancer Therapeutics Market Size by Country (2017-2022) 9.3 Latin America Prostate Cancer Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Prostate Cancer Therapeutics Introduction 11.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Detail 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Prostate Cancer Therapeutics Introduction 11.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.2.5 Pfizer Recent Development 11.3 Amgen 11.3.1 Amgen Company Detail 11.3.2 Amgen Business Overview 11.3.3 Amgen Prostate Cancer Therapeutics Introduction 11.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.3.5 Amgen Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Detail 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction 11.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.4.5 Johnson & Johnson Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Detail 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction 11.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.5.5 AstraZeneca Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Detail 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Prostate Cancer Therapeutics Introduction 11.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.6.5 AbbVie Recent Development 11.7 Bayer 11.7.1 Bayer Company Detail 11.7.2 Bayer Business Overview 11.7.3 Bayer Prostate Cancer Therapeutics Introduction 11.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.7.5 Bayer Recent Development 11.8 Ipsen Group 11.8.1 Ipsen Group Company Detail 11.8.2 Ipsen Group Business Overview 11.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction 11.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.8.5 Ipsen Group Recent Development 11.9 Endo Pharmaceuticals 11.9.1 Endo Pharmaceuticals Company Detail 11.9.2 Endo Pharmaceuticals Business Overview 11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction 11.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.9.5 Endo Pharmaceuticals Recent Development 11.10 Dendreon Corporation(Sanpower Group Co. Ltd.) 11.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Detail 11.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview 11.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction 11.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022) 11.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Prostate Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Drugs Table 3. Key Players of Medical Devices Table 4. Global Prostate Cancer Therapeutics Market Size Growth by Sale Channel (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Prostate Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Prostate Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Prostate Cancer Therapeutics Market Share by Region (2017-2022) Table 8. Global Prostate Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Prostate Cancer Therapeutics Market Share by Region (2023-2028) Table 10. Prostate Cancer Therapeutics Market Trends Table 11. Prostate Cancer Therapeutics Market Drivers Table 12. Prostate Cancer Therapeutics Market Challenges Table 13. Prostate Cancer Therapeutics Market Restraints Table 14. Global Prostate Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Prostate Cancer Therapeutics Market Share by Players (2017-2022) Table 16. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2021) Table 17. Ranking of Global Top Prostate Cancer Therapeutics Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prostate Cancer Therapeutics Product Solution and Service Table 21. Date of Enter into Prostate Cancer Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2017-2022) Table 25. Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2023-2028) Table 27. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million) Table 28. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2017-2022) Table 29. Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2023-2028) & (US$ Million) Table 30. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2023-2028) Table 31. North America Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 41. Sanofi Company Detail Table 42. Sanofi Business Overview Table 43. Sanofi Prostate Cancer Therapeutics Product Table 44. Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 45. Sanofi Recent Development Table 46. Pfizer Company Detail Table 47. Pfizer Business Overview Table 48. Pfizer Prostate Cancer Therapeutics Product Table 49. Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 50. Pfizer Recent Development Table 51. Amgen Company Detail Table 52. Amgen Business Overview Table 53. Amgen Prostate Cancer Therapeutics Product Table 54. Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 55. Amgen Recent Development Table 56. Johnson & Johnson Company Detail Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson Prostate Cancer Therapeutics Product Table 59. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 60. Johnson & Johnson Recent Development Table 61. AstraZeneca Company Detail Table 62. AstraZeneca Business Overview Table 63. AstraZeneca Prostate Cancer Therapeutics Product Table 64. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 65. AstraZeneca Recent Development Table 66. AbbVie Company Detail Table 67. AbbVie Business Overview Table 68. AbbVie Prostate Cancer Therapeutics Product Table 69. AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 70. AbbVie Recent Development Table 71. Bayer Company Detail Table 72. Bayer Business Overview Table 73. Bayer Prostate Cancer Therapeutics Product Table 74. Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 75. Bayer Recent Development Table 76. Ipsen Group Company Detail Table 77. Ipsen Group Business Overview Table 78. Ipsen Group Prostate Cancer Therapeutics Product Table 79. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 80. Ipsen Group Recent Development Table 81. Endo Pharmaceuticals Company Detail Table 82. Endo Pharmaceuticals Business Overview Table 83. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Table 84. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 85. Endo Pharmaceuticals Recent Development Table 86. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Detail Table 87. Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview Table 88. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Table 89. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 90. Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Drugs Features Figure 3. Medical Devices Features Figure 4. Global Prostate Cancer Therapeutics Market Share by Sale Channel in 2021 & 2028 Figure 5. Hospital Pharmacy Case Studies Figure 6. Retail Pharmacy Case Studies Figure 7. Online Sales Case Studies Figure 8. Prostate Cancer Therapeutics Report Years Considered Figure 9. Global Prostate Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Prostate Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Prostate Cancer Therapeutics Market Share by Region: 2021 VS 2028 Figure 12. Global Prostate Cancer Therapeutics Market Share by Players in 2021 Figure 13. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2021 Figure 15. North America Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Prostate Cancer Therapeutics Market Share by Country (2017-2028) Figure 17. United States Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Prostate Cancer Therapeutics Market Share by Country (2017-2028) Figure 21. Germany Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Prostate Cancer Therapeutics Market Share by Region (2017-2028) Figure 29. China Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Prostate Cancer Therapeutics Market Share by Country (2017-2028) Figure 37. Mexico Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Prostate Cancer Therapeutics Market Share by Country (2017-2028) Figure 41. Turkey Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 44. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 45. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 46. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 47. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 48. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 49. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 50. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 51. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 52. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed
Sanofi Pfizer Amgen Johnson & Johnson AstraZeneca AbbVie Bayer Ipsen Group Endo Pharmaceuticals Dendreon Corporation(Sanpower Group Co. Ltd.)
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Ionic Exchange Based Liquid Nuclear Waste Treatment market is segmented by players, region (count ... Read More
Oil and Gas Pipeline Leak Detection market is segmented by players, region (country), by Type and ... Read More